Vericel (VCEL) Change in Acquisitions & Divestments (2010 - 2026)
Vericel (VCEL) reported Change in Acquisitions & Divestments of $14.2 million for Q1 2026, up 13.99% on a YoY basis from $12.5 million in Q1 2025, and down 2.74% sequentially from $14.6 million in Q4 2025.
Vericel (VCEL) Change in Acquisitions & Divestments (2010 - 2026) Analysis & Trends
Vericel (VCEL) has 10 years of Change in Acquisitions & Divestments data on file, last reported at $14.2 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Acquisitions & Divestments rose 13.99% year-over-year to $14.2 million; the trailing twelve-month figure through Mar 2026 stood at $57.3 million (up 5.16% YoY), and the FY2025 full-year result was $55.6 million, up 4.6% from the prior year.
- Change in Acquisitions & Divestments slipped to $14.2 million in Q1 2026, from $14.6 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $21.5 million in Q1 2023 to a low of $5.0 million in Q4 2022.
- A 5-year average of $14.3 million and a median of $14.6 million in 2025 frame the typical range for Change in Acquisitions & Divestments.
- Across the five-year window, Change in Acquisitions & Divestments tumbled 79.8% in 2022 and jumped 326.5% in 2023, its largest moves.
- Tracing VCEL's Change in Acquisitions & Divestments over 5 years: stood at $5.0 million in 2022, then jumped by 274.36% to $18.7 million in 2023, then slipped by 21.28% to $14.7 million in 2024, then decreased by 0.58% to $14.6 million in 2025, then decreased by 2.74% to $14.2 million in 2026.
- Business Quant data shows VCEL's Change in Acquisitions & Divestments at $14.2 million in Q1 2026, $14.6 million in Q4 2025, and $13.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Vericel | 2.30 Bn | 2.15 Bn | 49.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.25 Mn |
| Mar 31, 2026 | 14.25 Mn |
| Dec 31, 2025 | 14.65 Mn |
| Dec 31, 2025 | 14.65 Mn |
| Sep 30, 2025 | 13.80 Mn |
| Sep 30, 2025 | 13.80 Mn |
| Jun 30, 2025 | 14.65 Mn |
| Jun 30, 2025 | 14.65 Mn |
| Mar 31, 2025 | 12.50 Mn |
| Mar 31, 2025 | 12.50 Mn |
| Dec 31, 2024 | 14.74 Mn |
| Dec 31, 2024 | 14.74 Mn |
| Sep 30, 2024 | 15.11 Mn |
| Sep 30, 2024 | 15.11 Mn |
| Jun 30, 2024 | 12.19 Mn |
| Jun 30, 2024 | 12.19 Mn |
| Mar 31, 2024 | 11.12 Mn |
| Mar 31, 2024 | 11.12 Mn |
| Dec 31, 2023 | 18.72 Mn |
| Dec 31, 2023 | 18.72 Mn |